Forcyte Biotechnologies
InactiveDiscover drugs that control how much cells "squeeze" to treat disease
What it does
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.
Next to it in Healthcare and bio · Mechanobiology drug discovery platform
- Output BiosciencesY Combinator S21
The foundation for the next era of biology
- Parallel BioY Combinator S21
Using the immune system to cure disease
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- FluoSpheraSOSV SOSV IndieBio NY 05
Drug Discovery without animals
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines
- Silene BiotechTechstars TS 2017
silenebiotech.com
- EVQLVTechstars TS 2020
EVQLV: Accelerating the speed that healing reaches those in need
- Diffuse BioY Combinator W23
Generative AI for protein design